S 2027 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Prescription Information Modernization Act of 2025
To provide for digital communication of prescribing information for drugs (including biological products), and for other purposes.
Summary
This bill would allow manufacturers to provide FDA-approved prescribing information for drugs in digital form rather than requiring paper labeling. Prescribers and dispensers would retain the option to receive paper copies if they prefer, and manufacturers would be required to provide paper labeling promptly at no additional cost upon request. The bill requires the Secretary of Health and Human Services to issue final regulations within one year that implement this digital option and provide instructions for obtaining paper copies, along with a public workshop within two years to discuss optimizing the format and accessibility of prescribing information. The digital option would apply to drugs introduced into commerce either two years after the bill's enactment or when the final regulations take effect, whichever comes first.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
1 cosponsor
- Sen. Booker, Cory A. [D-NJ] (D-NJ)
Actions (2)
- Jun 11, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- Jun 11, 2025 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
June 11, 2025
Mr. Mullin (for himself and Mr. Booker) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To provide for digital communication of prescribing information for drugs (including biological products), and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Prescription Information Modernization Act of 2025”.
SEC. 2. DIGITAL COMMUNICATION OF FDA-APPROVED PRESCRIBING INFORMATION FOR DRUGS (INCLUDING BIOLOGICAL PRODUCTS).
(a) In General.—Section 502(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352(f)) is amended by adding at the end the following: “Required prescribing information for drugs subject to section 503(b)(1) may be made available solely by electronic means, provided that the labeling complies with all applicable requirements of law, that the manufacturer affords prescribers and dispensers the opportunity to elect to also continue to receive all such information in paper form or to request paper labeling on an as-needed basis, and, after such request, that the manufacturer promptly provides the requested information without additional cost.”.
(b) Rulemaking.—
(1) In general.—Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue final regulations to—
(A) implement the amendment made by subsection (a); and
(B) provide instructions on how health care professionals can receive paper copies of prescribing information directly from the manufacturer or distributor if desired.
(2) Economic impacts.—The Secretary of Health and Human Services shall design the regulations required by paragraph (1) so as to minimize the adverse economic impacts of such regulations on prescribers and dispensers.
(c) Public Workshop.—Not later than 2 years after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall hold a public workshop with relevant stakeholders to discuss how to continue to optimize the format, accessibility, and usability of prescribing information.
(d) Effective Date.—The amendment made by subsection (a) shall apply with respect to drugs introduced or delivered for introduction into interstate commerce on or after the sooner of—
(1) the date that is 2 years after the date of the enactment of this Act; or
(2) the effective date of the final regulations promulgated to implement such amendment.
(e) Definition.—In this section, the term “drug” has the meaning given to such term in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). <all>
Comments